Literature DB >> 20972541

Sacral neuromodulation stimulation for IC/PBS, chronic pelvic pain, and sexual dysfunction.

Jennifer Yonaitis Fariello1, K Whitmore.   

Abstract

This study aims to review the use of sacral neuromodulation in the patient population with painful bladder syndrome/interstitial cystitis (PBS/IC), chronic pelvic pain (CPP), and sexual dysfunction. A literature review of the current research was carried out. This article highlights the current research findings and uses of sacral neuromodulation in patients with PBS/IC, CPP, vulvar vestibulitis, and erectile dysfunction. Current research on sacral neuromodulation on the abovementioned patient population has shown potential efficacy in pilot studies, though larger, multi-centered trials with long-term follow-up are needed.

Entities:  

Mesh:

Year:  2010        PMID: 20972541     DOI: 10.1007/s00192-010-1281-3

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  41 in total

1.  Gynecologic manifestations of interstitial cystitis.

Authors:  Deborah L Myers; Vivian C Aguilar
Journal:  Clin Obstet Gynecol       Date:  2002-03       Impact factor: 2.190

2.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Am J Obstet Gynecol       Date:  2002-07       Impact factor: 8.661

3.  Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study.

Authors:  Craig V Comiter
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

4.  Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome.

Authors:  J M Weiss
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

Review 5.  Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature.

Authors:  I P Spector; M P Carey
Journal:  Arch Sex Behav       Date:  1990-08

6.  Effects of sacral neuromodulation on female sexual function.

Authors:  Rachel N Pauls; Serge P Marinkovic; W Andre Silva; Christopher M Rooney; Steven D Kleeman; Mickey M Karram
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-07-26

7.  Percutaneous sacral nerve root neuromodulation for intractable interstitial cystitis.

Authors:  C F Maher; M P Carey; P L Dwyer; P L Schluter
Journal:  J Urol       Date:  2001-03       Impact factor: 7.450

Review 8.  Chronic prostatitis/chronic pelvic pain syndrome and male interstitial cystitis: enigmas and opportunities.

Authors:  John B Forrest; J Curtis Nickel; Robert M Moldwin
Journal:  Urology       Date:  2007-04       Impact factor: 2.649

9.  Sacral neuromodulation for the treatment of refractory interstitial cystitis: outcomes based on technique.

Authors:  Kenneth M Peters; Jeffrey M Carey; David B Konstandt
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-08-26

10.  Sacral neuromodulation in patients with interstitial cystitis: a multicenter clinical trial.

Authors:  Kristene E Whitmore; Christopher K Payne; Ananias C Diokno; James Chivian Lukban
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-09-06
View more
  10 in total

Review 1.  Sacral neuromodulation and female sexuality.

Authors:  Giuseppe Lombardi; Enrico Finazzi Agrò; Giulio Del Popolo
Journal:  Int Urogynecol J       Date:  2015-04-16       Impact factor: 2.894

2.  Outcomes of implementation of sacral nerve stimulation on urination, defecation, and sexual function in patients with spinal cord injury.

Authors:  Abbas Norouzi Javidan; Klaus Mazel; Sahar Latifi; Mohammad Mohsen Maghari; Hooshang Saberi; Abolghasem Nikfalah; S Adeleh Mirjafari Daryasari; Mir Saeed Yekaninejad
Journal:  Int J Colorectal Dis       Date:  2014-06-21       Impact factor: 2.571

3.  The effect of percutaneous tibial nerve stimulation (PTNS) on sexual function: a systematic review and meta-analysis.

Authors:  Victoria Kershaw; Aethele Khunda; Carol McCormick; Paul Ballard
Journal:  Int Urogynecol J       Date:  2019-07-05       Impact factor: 2.894

Review 4.  Animal Models for the Study of Female Sexual Dysfunction.

Authors:  Lesley Marson; Maria Adele Giamberardino; Raffaele Costantini; Peter Czakanski; Ursula Wesselmann
Journal:  Sex Med Rev       Date:  2015-10-18

Review 5.  Neuromodulation for Chronic Pelvic Pain.

Authors:  Justina Tam; Charles Loeb; Daniel Grajower; Jason Kim; Steven Weissbart
Journal:  Curr Urol Rep       Date:  2018-03-26       Impact factor: 3.092

Review 6.  Neuropelveology: An Emerging Discipline for the Management of Chronic Pelvic Pain.

Authors:  Marc Possover; Karl-Erik Andersson; Axel Forman
Journal:  Int Neurourol J       Date:  2017-12-31       Impact factor: 2.835

7.  Outcomes of Implementation of Sacral Nerve Stimulation in Incontinent Patients in Shiraz.

Authors:  Alimohammad Bananzadeh; Seyed Vahid Hosseini; Ahmad Izadpanah; Alireza Izadi; Hajar Khazraei; Mozhdeh Zamani; Faranak Bahrami
Journal:  Adv Biomed Res       Date:  2019-03-20

8.  Caudal Neuromodulation with the Transforaminal Sacral Electrode (InterStim®): Experience in a Pain Center Regarding 12 Implants.

Authors:  Laura Alonso Guardo; Carlos Cano Gala; David Sánchez Poveda; Pablo Rueda Juan; Francisco José Sánchez Montero; José Carlos Garzón Sánchez; Juan Ignacio Santos Lamas; Miguel Vicente Sánchez Hernández
Journal:  Korean J Pain       Date:  2016-01-04

9.  Sacral neuromodulation - when and for who.

Authors:  Marcelo Mass-Lindenbaum; D Calderón-Pollak; H B Goldman; Javier Pizarro-Berdichevsky
Journal:  Int Braz J Urol       Date:  2021 May-Jun       Impact factor: 1.541

10.  Long-term Outcomes of Sacral Nerve Stimulation in Pelvic Floor Dysfunctions.

Authors:  David Hernández-Hernández; Bárbara Padilla-Fernández; Milagros Castro Romera; Stephany Hess Medler; David Castro-Díaz
Journal:  Int Neurourol J       Date:  2021-01-27       Impact factor: 2.835

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.